Blood Flow Restriction Therapy for Tennis Elbow
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are actively being treated with anticoagulants (blood thinners), you cannot participate.
What data supports the effectiveness of the treatment Blood Flow Restriction Therapy for Tennis Elbow?
Research shows that low-load resistance training with blood flow restriction (BFR) significantly reduces pain and improves grip strength in patients with tennis elbow compared to a similar treatment without BFR. This suggests that BFR can be an effective part of rehabilitation for this condition.12345
Is Blood Flow Restriction Therapy safe for humans?
How does blood flow restriction therapy differ from other treatments for tennis elbow?
Blood flow restriction therapy is unique because it involves exercising with restricted blood flow, which helps build muscle strength and reduce pain without needing heavy weights. This makes it particularly useful for people recovering from injuries like tennis elbow, where traditional high-load exercises might not be feasible.14678
What is the purpose of this trial?
Lateral epicondylitis (LE), often referred to as "tennis elbow" is a common and debilitating overuse injury affecting 1-3% of adults annually. LE is most often defined as a syndrome of pain near the area of the lateral epicondyle of the elbow commonly effecting the origin of the extensor carpi radialis brevis with associated weakness; it most commonly effects the dominant arm. The best treatment for LE is unknown and research to support current treatment methods are insufficient. A common limitation in functional recovery experienced by this population is pain at the lateral aspect of the elbow. As such, innovative therapeutic interventions directed at quickly reducing pain may address this unmet need and allow for improved outcomes, as well as earlier return to function.
Research Team
Julia Nuelle, MD
Principal Investigator
University of Missouri Department of Orthopaedic Surgery
Eligibility Criteria
This trial is for adults aged 18-65 with tennis elbow confirmed by a surgeon and ultrasound. Participants must read/write English and consent themselves. Excluded are those with vascular diseases, bruising issues, infections, cancer, diabetes, prior injections for the condition, recent deep vein thrombosis, other arm disabilities, anticoagulant use or pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo physical therapy with or without blood flow restriction
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Blood Flow Restriction Device
- Standard Physical Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Julie Nuelle
Lead Sponsor